NRO Neurones SA

NEURONES: Organic growth up 5.4% in 1st quarter 2020

NEURONES: Organic growth up 5.4% in 1st quarter 2020

PRESS INFORMATION

Heading: 1st quarter 2020 revenues

Nanterre, May 6, 2020 (after the closing of the stock exchange)

Organic growth up 5.4% in 1st quarter 2020

(€ millions)Q1 2019Q1 2020growthof which organic
Revenues128.7135.3+5.1%+5.4%

Achievements

Despite the lockdown in effect since March 17, the Group achieved organic growth of +5.4% in the 1st quarter of 2020 (compared with +4.2% over the same period last year).

The operating profit (*) stood at 9.3% of revenues (compared with 9.5% for the 1st quarter of 2019 excluding exceptional capital gains).

Compared with the 2019 Universal Registration Document ( - Investors), the financial position (net cash of €218.3 million at December 31, 2019) has not changed significantly.

Outlook

Organic growth in the 1st quarter, a significant proportion of recurring managed services contracts, low exposure to affected sectors and a probable acceleration of the digital transformation constitute a favorable context. However, the fall in GDP announced at a minimum of -8% (for France) leads the Group to forecast revenues of approximately €475 million for 2020, with an operating profit of at least 6%.

In view of the current high exogenous uncertainties, this estimate is naturally less precise than those of previous years and may be revised in the light of the behavior of economic agents in the coming quarters, which is difficult to predict.

(*) unaudited and after inclusion of 0.2% expenses related to bonus shares.

About NEURONES

With 5,400 experts, the NEURONES Group specializes in Consulting (Management, Organization and Digital) and IT Services. It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD (deferred settlement) mid-caps

Press Relations:

O'Connection

Floriane Monnier

Tel.: +33 (0)6 32 37 57 28

 



NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment

EN
06/05/2020

Underlying

NRONeurones SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2...

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2023 INFORMATION PRESSE Rubrique : Document d’Enregistrement Universel 2023 Nanterre, le 25 avril 2024 Mise à disposition du Document d’Enregistrement Universel 2023 Le Document d’Enregistrement Universel 2023 a été déposé auprès de l’Autorité des Marchés Financiers (AMF). Il inclut le rapport financier annuel. Conformément à l’article 212-13 du Règlement général de l’AMF, il est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation : il est accessible dès ce jour, sous format...

4h / 3m 1 EN
Pierre Dinet (IDMidCaps)
  • Pierre Dinet (IDMidCaps)
NRO NEURONES SA

Neurones - The best performance in the sector in 2023

2-digit organic growth for 3rd consecutive yearSlight contraction in profitability, but Operating EBIT on Activity up vs main comparablesContinued growth in 2024, though probably at a slower paceOn course for €300 million in net cash in the absence of M&A or exceptional dividendsValuation has increased, leaving less upside, excluding any control premium, in a context of sector consolidation, but Neurones offers the best visibility in the sector.

03/14/24 March 14, 2024 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: Net profit (group share) up 11.5% in 2023

NEURONES: Net profit (group share) up 11.5% in 2023 PRESS INFORMATIONHeading: 2023 annual results        Nanterre, March 6, 2024 (after trading) Net profit (group share) up 11.5% in 2023 Financial statements at December 31 (1)20222023Revenues665.4741.2Business operating profit (2)77 (11.6%)81.5 (11%)Operating profit72.9 (11%)75.9 (10.2%)Financial profit04.9Tax on earnings(21.1)(22.2)Net profit51.8 (7.8%)58.6 (7.9%)- of which, group share44.349.4Free cash flow (3)37.651.6Cash and cash equivalents (net of financial debt) (4)271.8290.4Staff at year-end6,4066,749 (1)        In millions of euro...

March 6, 2024 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : Résultat net part du groupe en croissance de + 11,5% en 202...

NEURONES : Résultat net part du groupe en croissance de + 11,5% en 2023 INFORMATION PRESSERubrique : Résultats annuels 2023        Nanterre, le 6 mars 2024 (après Bourse) Résultat net part du groupe en croissance de + 11,5% en 2023 Comptes au 31 décembre (1)20222023Chiffre d’affaires665,4741,2Résultat opérationnel d’activité (2)77 (11,6%)81,5 (11%)Résultat opérationnel72,9 (11%)75,9 (10,2%)Résultat financier04,9Impôt sur les résultats(21,1)(22,2)Résultat net51,8 (7,8%)58,6 (7,9%)- dont part du groupe44,349,4Cash-flow libre (3)37,651,6Trésorerie nette d’endettement financier (4)271,8290,4Ef...

March 6, 2024 1 EN
Pierre Dinet (IDMidCaps)
  • Pierre Dinet (IDMidCaps)
NRO NEURONES SA

Neurones - Another good Q4 confirms excellent track record

Once again, the Group does not disappoint and (modestly) exceeds its guidance for the 5th consecutive yearEBIT Margin still in 2 digits in 2023, among the best in the sectorValuation reflects the Group's excellent fundamentalsThe most solid IT services provider in terms of track record and balance sheet. The upside is now a little more limited, but does not include a control premium as the sector consolidates and the founder's succession is not yet fully finalized.

02/20/24 February 20, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch